← All organizations

MAPS Public Benefit Corporation

MAPS Public Benefit Corporation

Academic/HospitalWebsite ↗

Also known as: MAPS Public Benefit Corp. | MAPS Public Benefit Corporation

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Jan 2, 2024

Timeline

1980s

Jun 1, 1986
MAPS Public Benefit Corporation— Founded

Drugs by trial phase (1 distinct, 13 trials)

Phase 3 (1 own, 0 via acquisition)

3,4-Methylenedioxymethamphetamine

Indications

Studied for

Recent trials (13)

NCT04438512Study directorN/A—
NCT06117306CollaboratorPhase 3Jan 2, 2024
NCT05979844CollaboratorPhase 3Oct 6, 2023
NCT04714359Study directorPhase 3Mar 26, 2021
NCT04454684Study directorPhase 2Nov 30, 2020
NCT04077437Study directorPhase 3Jan 31, 2020
NCT04073433Study directorPhase 1Oct 31, 2019
NCT04030169Study directorPhase 2Aug 31, 2019
NCT03537014Study directorPhase 3Oct 10, 2018
NCT03485287Study directorPhase 2Mar 9, 2018
NCT03282123Study directorPhase 2Oct 24, 2017
NCT03181763Lead sponsorPhase 1Sep 21, 2017
NCT01793610Study chairPhase 2Apr 1, 2013

Details

Founded: Santa Cruz, CA, US Jun 1, 1986
Last known activity: Jan 2, 2024